nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Vismodegib—skin cancer	0.139	0.557	CbGbCtD
Terazosin—ABCB1—Dactinomycin—skin cancer	0.0728	0.292	CbGbCtD
Terazosin—ABCB1—Docetaxel—skin cancer	0.0376	0.151	CbGbCtD
Terazosin—Nasopharyngitis—Fluorouracil—skin cancer	0.00228	0.00304	CcSEcCtD
Terazosin—Constipation—Vemurafenib—skin cancer	0.00228	0.00303	CcSEcCtD
Terazosin—Oedema—Imiquimod—skin cancer	0.00227	0.00303	CcSEcCtD
Terazosin—Dysuria—Temozolomide—skin cancer	0.00224	0.00298	CcSEcCtD
Terazosin—Shock—Imiquimod—skin cancer	0.00224	0.00298	CcSEcCtD
Terazosin—Tachycardia—Imiquimod—skin cancer	0.00222	0.00295	CcSEcCtD
Terazosin—Pollakiuria—Temozolomide—skin cancer	0.00221	0.00295	CcSEcCtD
Terazosin—Erectile dysfunction—Temozolomide—skin cancer	0.00221	0.00294	CcSEcCtD
Terazosin—Hyperhidrosis—Imiquimod—skin cancer	0.0022	0.00292	CcSEcCtD
Terazosin—Photosensitivity reaction—Temozolomide—skin cancer	0.00219	0.00291	CcSEcCtD
Terazosin—Weight increased—Temozolomide—skin cancer	0.00218	0.0029	CcSEcCtD
Terazosin—Anorexia—Imiquimod—skin cancer	0.00217	0.00288	CcSEcCtD
Terazosin—Angina pectoris—Fluorouracil—skin cancer	0.00215	0.00286	CcSEcCtD
Terazosin—Depression—Temozolomide—skin cancer	0.00213	0.00283	CcSEcCtD
Terazosin—Body temperature increased—Vemurafenib—skin cancer	0.00211	0.0028	CcSEcCtD
Terazosin—Pharyngitis—Dactinomycin—skin cancer	0.0021	0.0028	CcSEcCtD
Terazosin—Urinary tract infection—Temozolomide—skin cancer	0.00208	0.00276	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00207	0.00276	CcSEcCtD
Terazosin—Insomnia—Imiquimod—skin cancer	0.00206	0.00274	CcSEcCtD
Terazosin—Paraesthesia—Imiquimod—skin cancer	0.00204	0.00272	CcSEcCtD
Terazosin—Dyspnoea—Imiquimod—skin cancer	0.00203	0.0027	CcSEcCtD
Terazosin—Somnolence—Imiquimod—skin cancer	0.00202	0.00269	CcSEcCtD
Terazosin—Photosensitivity reaction—Fluorouracil—skin cancer	0.00201	0.00268	CcSEcCtD
Terazosin—Sinusitis—Temozolomide—skin cancer	0.002	0.00267	CcSEcCtD
Terazosin—Dyspepsia—Imiquimod—skin cancer	0.002	0.00266	CcSEcCtD
Terazosin—Decreased appetite—Imiquimod—skin cancer	0.00198	0.00263	CcSEcCtD
Terazosin—Hypersensitivity—Vemurafenib—skin cancer	0.00196	0.00261	CcSEcCtD
Terazosin—Fatigue—Imiquimod—skin cancer	0.00196	0.00261	CcSEcCtD
Terazosin—Atrial fibrillation—Docetaxel—skin cancer	0.00194	0.00259	CcSEcCtD
Terazosin—Pain—Imiquimod—skin cancer	0.00194	0.00259	CcSEcCtD
Terazosin—Conjunctivitis—Fluorouracil—skin cancer	0.00191	0.00255	CcSEcCtD
Terazosin—Urinary tract infection—Fluorouracil—skin cancer	0.00191	0.00255	CcSEcCtD
Terazosin—Asthenia—Vemurafenib—skin cancer	0.00191	0.00255	CcSEcCtD
Terazosin—Pharyngitis—Temozolomide—skin cancer	0.0019	0.00253	CcSEcCtD
Terazosin—Oedema peripheral—Temozolomide—skin cancer	0.00189	0.00251	CcSEcCtD
Terazosin—Cardiac failure—Docetaxel—skin cancer	0.00189	0.00251	CcSEcCtD
Terazosin—Pruritus—Vemurafenib—skin cancer	0.00189	0.00251	CcSEcCtD
Terazosin—Feeling abnormal—Imiquimod—skin cancer	0.00187	0.00249	CcSEcCtD
Terazosin—Gastrointestinal pain—Imiquimod—skin cancer	0.00186	0.00247	CcSEcCtD
Terazosin—Epistaxis—Fluorouracil—skin cancer	0.00186	0.00247	CcSEcCtD
Terazosin—Visual impairment—Temozolomide—skin cancer	0.00185	0.00246	CcSEcCtD
Terazosin—Sinusitis—Fluorouracil—skin cancer	0.00185	0.00246	CcSEcCtD
Terazosin—Pain in extremity—Docetaxel—skin cancer	0.00184	0.00245	CcSEcCtD
Terazosin—Ill-defined disorder—Bleomycin—skin cancer	0.00184	0.00244	CcSEcCtD
Terazosin—Diarrhoea—Vemurafenib—skin cancer	0.00182	0.00243	CcSEcCtD
Terazosin—Migraine—Docetaxel—skin cancer	0.00181	0.00241	CcSEcCtD
Terazosin—Body temperature increased—Imiquimod—skin cancer	0.0018	0.00239	CcSEcCtD
Terazosin—Abdominal pain—Imiquimod—skin cancer	0.0018	0.00239	CcSEcCtD
Terazosin—Eye disorder—Temozolomide—skin cancer	0.00179	0.00238	CcSEcCtD
Terazosin—Tinnitus—Temozolomide—skin cancer	0.00179	0.00238	CcSEcCtD
Terazosin—Malaise—Bleomycin—skin cancer	0.00178	0.00237	CcSEcCtD
Terazosin—Rhinitis—Fluorouracil—skin cancer	0.00177	0.00236	CcSEcCtD
Terazosin—Dizziness—Vemurafenib—skin cancer	0.00176	0.00235	CcSEcCtD
Terazosin—Pharyngitis—Fluorouracil—skin cancer	0.00175	0.00233	CcSEcCtD
Terazosin—Cough—Bleomycin—skin cancer	0.00173	0.0023	CcSEcCtD
Terazosin—Ill-defined disorder—Dactinomycin—skin cancer	0.00171	0.00228	CcSEcCtD
Terazosin—Vomiting—Vemurafenib—skin cancer	0.00169	0.00226	CcSEcCtD
Terazosin—Myalgia—Bleomycin—skin cancer	0.00168	0.00224	CcSEcCtD
Terazosin—Chest pain—Bleomycin—skin cancer	0.00168	0.00224	CcSEcCtD
Terazosin—Orthostatic hypotension—Docetaxel—skin cancer	0.00168	0.00224	CcSEcCtD
Terazosin—Rash—Vemurafenib—skin cancer	0.00168	0.00224	CcSEcCtD
Terazosin—Dermatitis—Vemurafenib—skin cancer	0.00168	0.00223	CcSEcCtD
Terazosin—Hypersensitivity—Imiquimod—skin cancer	0.00167	0.00223	CcSEcCtD
Terazosin—Headache—Vemurafenib—skin cancer	0.00167	0.00222	CcSEcCtD
Terazosin—Malnutrition—Temozolomide—skin cancer	0.00167	0.00222	CcSEcCtD
Terazosin—Discomfort—Bleomycin—skin cancer	0.00166	0.00222	CcSEcCtD
Terazosin—Malaise—Dactinomycin—skin cancer	0.00166	0.00221	CcSEcCtD
Terazosin—Nasopharyngitis—Docetaxel—skin cancer	0.00165	0.00219	CcSEcCtD
Terazosin—Dysgeusia—Temozolomide—skin cancer	0.00163	0.00218	CcSEcCtD
Terazosin—Asthenia—Imiquimod—skin cancer	0.00163	0.00217	CcSEcCtD
Terazosin—Confusional state—Bleomycin—skin cancer	0.00163	0.00217	CcSEcCtD
Terazosin—Anaphylactic shock—Bleomycin—skin cancer	0.00161	0.00215	CcSEcCtD
Terazosin—Oedema—Bleomycin—skin cancer	0.00161	0.00215	CcSEcCtD
Terazosin—Back pain—Temozolomide—skin cancer	0.00161	0.00215	CcSEcCtD
Terazosin—Pruritus—Imiquimod—skin cancer	0.00161	0.00214	CcSEcCtD
Terazosin—Nausea—Vemurafenib—skin cancer	0.00158	0.00211	CcSEcCtD
Terazosin—Thrombocytopenia—Bleomycin—skin cancer	0.00158	0.0021	CcSEcCtD
Terazosin—Arrhythmia—Fluorouracil—skin cancer	0.00158	0.0021	CcSEcCtD
Terazosin—Vision blurred—Temozolomide—skin cancer	0.00157	0.00209	CcSEcCtD
Terazosin—Myalgia—Dactinomycin—skin cancer	0.00157	0.00209	CcSEcCtD
Terazosin—Tremor—Temozolomide—skin cancer	0.00156	0.00208	CcSEcCtD
Terazosin—Diarrhoea—Imiquimod—skin cancer	0.00156	0.00207	CcSEcCtD
Terazosin—Discomfort—Dactinomycin—skin cancer	0.00155	0.00207	CcSEcCtD
Terazosin—Angina pectoris—Docetaxel—skin cancer	0.00155	0.00207	CcSEcCtD
Terazosin—Ill-defined disorder—Temozolomide—skin cancer	0.00155	0.00206	CcSEcCtD
Terazosin—Anorexia—Bleomycin—skin cancer	0.00154	0.00205	CcSEcCtD
Terazosin—Angioedema—Temozolomide—skin cancer	0.00152	0.00203	CcSEcCtD
Terazosin—Hypotension—Bleomycin—skin cancer	0.00151	0.00201	CcSEcCtD
Terazosin—Oedema—Dactinomycin—skin cancer	0.00151	0.002	CcSEcCtD
Terazosin—Malaise—Temozolomide—skin cancer	0.0015	0.002	CcSEcCtD
Terazosin—Dizziness—Imiquimod—skin cancer	0.0015	0.002	CcSEcCtD
Terazosin—Vertigo—Temozolomide—skin cancer	0.0015	0.002	CcSEcCtD
Terazosin—Palpitations—Temozolomide—skin cancer	0.00147	0.00196	CcSEcCtD
Terazosin—Thrombocytopenia—Dactinomycin—skin cancer	0.00147	0.00196	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00147	0.00196	CcSEcCtD
Terazosin—Cough—Temozolomide—skin cancer	0.00146	0.00194	CcSEcCtD
Terazosin—Paraesthesia—Bleomycin—skin cancer	0.00145	0.00193	CcSEcCtD
Terazosin—Weight increased—Docetaxel—skin cancer	0.00145	0.00193	CcSEcCtD
Terazosin—Vision blurred—Fluorouracil—skin cancer	0.00145	0.00193	CcSEcCtD
Terazosin—Convulsion—Temozolomide—skin cancer	0.00145	0.00192	CcSEcCtD
Terazosin—Vomiting—Imiquimod—skin cancer	0.00145	0.00192	CcSEcCtD
Terazosin—Dyspnoea—Bleomycin—skin cancer	0.00144	0.00192	CcSEcCtD
Terazosin—Anorexia—Dactinomycin—skin cancer	0.00144	0.00191	CcSEcCtD
Terazosin—Rash—Imiquimod—skin cancer	0.00143	0.00191	CcSEcCtD
Terazosin—Dermatitis—Imiquimod—skin cancer	0.00143	0.00191	CcSEcCtD
Terazosin—Headache—Imiquimod—skin cancer	0.00142	0.0019	CcSEcCtD
Terazosin—Arthralgia—Temozolomide—skin cancer	0.00142	0.00189	CcSEcCtD
Terazosin—Myalgia—Temozolomide—skin cancer	0.00142	0.00189	CcSEcCtD
Terazosin—Anxiety—Temozolomide—skin cancer	0.00142	0.00188	CcSEcCtD
Terazosin—Discomfort—Temozolomide—skin cancer	0.0014	0.00187	CcSEcCtD
Terazosin—Decreased appetite—Bleomycin—skin cancer	0.0014	0.00187	CcSEcCtD
Terazosin—Dry mouth—Temozolomide—skin cancer	0.00139	0.00185	CcSEcCtD
Terazosin—Jaundice—Docetaxel—skin cancer	0.00138	0.00184	CcSEcCtD
Terazosin—Pain—Bleomycin—skin cancer	0.00138	0.00184	CcSEcCtD
Terazosin—Conjunctivitis—Docetaxel—skin cancer	0.00138	0.00184	CcSEcCtD
Terazosin—Confusional state—Temozolomide—skin cancer	0.00137	0.00183	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00137	0.00183	CcSEcCtD
Terazosin—Oedema—Temozolomide—skin cancer	0.00136	0.00181	CcSEcCtD
Terazosin—Anaphylactic shock—Temozolomide—skin cancer	0.00136	0.00181	CcSEcCtD
Terazosin—Nausea—Imiquimod—skin cancer	0.00135	0.0018	CcSEcCtD
Terazosin—Epistaxis—Docetaxel—skin cancer	0.00134	0.00178	CcSEcCtD
Terazosin—Thrombocytopenia—Temozolomide—skin cancer	0.00133	0.00178	CcSEcCtD
Terazosin—Convulsion—Fluorouracil—skin cancer	0.00133	0.00177	CcSEcCtD
Terazosin—Feeling abnormal—Bleomycin—skin cancer	0.00133	0.00177	CcSEcCtD
Terazosin—Hyperhidrosis—Temozolomide—skin cancer	0.00132	0.00175	CcSEcCtD
Terazosin—Chest pain—Fluorouracil—skin cancer	0.00131	0.00174	CcSEcCtD
Terazosin—Myalgia—Fluorouracil—skin cancer	0.00131	0.00174	CcSEcCtD
Terazosin—Decreased appetite—Dactinomycin—skin cancer	0.00131	0.00174	CcSEcCtD
Terazosin—Fatigue—Dactinomycin—skin cancer	0.0013	0.00173	CcSEcCtD
Terazosin—Anorexia—Temozolomide—skin cancer	0.0013	0.00173	CcSEcCtD
Terazosin—Discomfort—Fluorouracil—skin cancer	0.00129	0.00172	CcSEcCtD
Terazosin—Pain—Dactinomycin—skin cancer	0.00129	0.00171	CcSEcCtD
Terazosin—Rhinitis—Docetaxel—skin cancer	0.00128	0.0017	CcSEcCtD
Terazosin—Body temperature increased—Bleomycin—skin cancer	0.00128	0.0017	CcSEcCtD
Terazosin—Confusional state—Fluorouracil—skin cancer	0.00127	0.00168	CcSEcCtD
Terazosin—Pharyngitis—Docetaxel—skin cancer	0.00127	0.00168	CcSEcCtD
Terazosin—Oedema peripheral—Docetaxel—skin cancer	0.00126	0.00167	CcSEcCtD
Terazosin—Oedema—Fluorouracil—skin cancer	0.00125	0.00167	CcSEcCtD
Terazosin—Anaphylactic shock—Fluorouracil—skin cancer	0.00125	0.00167	CcSEcCtD
Terazosin—Feeling abnormal—Dactinomycin—skin cancer	0.00124	0.00165	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00124	0.00165	CcSEcCtD
Terazosin—Insomnia—Temozolomide—skin cancer	0.00123	0.00164	CcSEcCtD
Terazosin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00123	0.00164	CcSEcCtD
Terazosin—Thrombocytopenia—Fluorouracil—skin cancer	0.00123	0.00164	CcSEcCtD
Terazosin—Visual impairment—Docetaxel—skin cancer	0.00123	0.00164	CcSEcCtD
Terazosin—Tachycardia—Fluorouracil—skin cancer	0.00122	0.00163	CcSEcCtD
Terazosin—Paraesthesia—Temozolomide—skin cancer	0.00122	0.00163	CcSEcCtD
Terazosin—Dyspnoea—Temozolomide—skin cancer	0.00121	0.00162	CcSEcCtD
Terazosin—Somnolence—Temozolomide—skin cancer	0.00121	0.00161	CcSEcCtD
Terazosin—Dyspepsia—Temozolomide—skin cancer	0.0012	0.0016	CcSEcCtD
Terazosin—Anorexia—Fluorouracil—skin cancer	0.0012	0.00159	CcSEcCtD
Terazosin—Eye disorder—Docetaxel—skin cancer	0.00119	0.00159	CcSEcCtD
Terazosin—Body temperature increased—Dactinomycin—skin cancer	0.00119	0.00158	CcSEcCtD
Terazosin—Abdominal pain—Dactinomycin—skin cancer	0.00119	0.00158	CcSEcCtD
Terazosin—Hypersensitivity—Bleomycin—skin cancer	0.00119	0.00158	CcSEcCtD
Terazosin—Decreased appetite—Temozolomide—skin cancer	0.00118	0.00158	CcSEcCtD
Terazosin—Fatigue—Temozolomide—skin cancer	0.00117	0.00156	CcSEcCtD
Terazosin—Hypotension—Fluorouracil—skin cancer	0.00117	0.00156	CcSEcCtD
Terazosin—Pain—Temozolomide—skin cancer	0.00116	0.00155	CcSEcCtD
Terazosin—Constipation—Temozolomide—skin cancer	0.00116	0.00155	CcSEcCtD
Terazosin—Asthenia—Bleomycin—skin cancer	0.00116	0.00154	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00114	0.00152	CcSEcCtD
Terazosin—Pruritus—Bleomycin—skin cancer	0.00114	0.00152	CcSEcCtD
Terazosin—Arrhythmia—Docetaxel—skin cancer	0.00114	0.00152	CcSEcCtD
Terazosin—Insomnia—Fluorouracil—skin cancer	0.00113	0.00151	CcSEcCtD
Terazosin—Paraesthesia—Fluorouracil—skin cancer	0.00113	0.0015	CcSEcCtD
Terazosin—Feeling abnormal—Temozolomide—skin cancer	0.00112	0.00149	CcSEcCtD
Terazosin—Dyspnoea—Fluorouracil—skin cancer	0.00112	0.00149	CcSEcCtD
Terazosin—Somnolence—Fluorouracil—skin cancer	0.00112	0.00149	CcSEcCtD
Terazosin—Gastrointestinal pain—Temozolomide—skin cancer	0.00111	0.00148	CcSEcCtD
Terazosin—Malnutrition—Docetaxel—skin cancer	0.00111	0.00148	CcSEcCtD
Terazosin—Hypersensitivity—Dactinomycin—skin cancer	0.00111	0.00148	CcSEcCtD
Terazosin—Dyspepsia—Fluorouracil—skin cancer	0.0011	0.00147	CcSEcCtD
Terazosin—Decreased appetite—Fluorouracil—skin cancer	0.00109	0.00145	CcSEcCtD
Terazosin—Dysgeusia—Docetaxel—skin cancer	0.00109	0.00145	CcSEcCtD
Terazosin—Asthenia—Dactinomycin—skin cancer	0.00108	0.00144	CcSEcCtD
Terazosin—Body temperature increased—Temozolomide—skin cancer	0.00108	0.00143	CcSEcCtD
Terazosin—Abdominal pain—Temozolomide—skin cancer	0.00108	0.00143	CcSEcCtD
Terazosin—Back pain—Docetaxel—skin cancer	0.00107	0.00143	CcSEcCtD
Terazosin—Pain—Fluorouracil—skin cancer	0.00107	0.00143	CcSEcCtD
Terazosin—Feeling abnormal—Fluorouracil—skin cancer	0.00103	0.00138	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—skin cancer	0.00103	0.00137	CcSEcCtD
Terazosin—Vomiting—Bleomycin—skin cancer	0.00103	0.00137	CcSEcCtD
Terazosin—Rash—Bleomycin—skin cancer	0.00102	0.00136	CcSEcCtD
Terazosin—Dermatitis—Bleomycin—skin cancer	0.00102	0.00135	CcSEcCtD
Terazosin—Hypersensitivity—Temozolomide—skin cancer	0.001	0.00134	CcSEcCtD
Terazosin—Syncope—Docetaxel—skin cancer	0.000995	0.00132	CcSEcCtD
Terazosin—Body temperature increased—Fluorouracil—skin cancer	0.000992	0.00132	CcSEcCtD
Terazosin—Palpitations—Docetaxel—skin cancer	0.000981	0.00131	CcSEcCtD
Terazosin—Asthenia—Temozolomide—skin cancer	0.000977	0.0013	CcSEcCtD
Terazosin—Loss of consciousness—Docetaxel—skin cancer	0.000975	0.0013	CcSEcCtD
Terazosin—Cough—Docetaxel—skin cancer	0.000968	0.00129	CcSEcCtD
Terazosin—Pruritus—Temozolomide—skin cancer	0.000964	0.00128	CcSEcCtD
Terazosin—Convulsion—Docetaxel—skin cancer	0.000962	0.00128	CcSEcCtD
Terazosin—Nausea—Bleomycin—skin cancer	0.000959	0.00128	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—skin cancer	0.000957	0.00127	CcSEcCtD
Terazosin—Rash—Dactinomycin—skin cancer	0.000949	0.00126	CcSEcCtD
Terazosin—Arthralgia—Docetaxel—skin cancer	0.000945	0.00126	CcSEcCtD
Terazosin—Chest pain—Docetaxel—skin cancer	0.000945	0.00126	CcSEcCtD
Terazosin—Myalgia—Docetaxel—skin cancer	0.000945	0.00126	CcSEcCtD
Terazosin—Diarrhoea—Temozolomide—skin cancer	0.000932	0.00124	CcSEcCtD
Terazosin—Hypersensitivity—Fluorouracil—skin cancer	0.000925	0.00123	CcSEcCtD
Terazosin—Dry mouth—Docetaxel—skin cancer	0.000924	0.00123	CcSEcCtD
Terazosin—Confusional state—Docetaxel—skin cancer	0.000913	0.00122	CcSEcCtD
Terazosin—Anaphylactic shock—Docetaxel—skin cancer	0.000906	0.00121	CcSEcCtD
Terazosin—Oedema—Docetaxel—skin cancer	0.000906	0.00121	CcSEcCtD
Terazosin—Dizziness—Temozolomide—skin cancer	0.000901	0.0012	CcSEcCtD
Terazosin—Nausea—Dactinomycin—skin cancer	0.000894	0.00119	CcSEcCtD
Terazosin—Shock—Docetaxel—skin cancer	0.000891	0.00119	CcSEcCtD
Terazosin—Pruritus—Fluorouracil—skin cancer	0.000888	0.00118	CcSEcCtD
Terazosin—Thrombocytopenia—Docetaxel—skin cancer	0.000887	0.00118	CcSEcCtD
Terazosin—Tachycardia—Docetaxel—skin cancer	0.000884	0.00118	CcSEcCtD
Terazosin—Vomiting—Temozolomide—skin cancer	0.000866	0.00115	CcSEcCtD
Terazosin—Anorexia—Docetaxel—skin cancer	0.000863	0.00115	CcSEcCtD
Terazosin—Rash—Temozolomide—skin cancer	0.000859	0.00114	CcSEcCtD
Terazosin—Diarrhoea—Fluorouracil—skin cancer	0.000859	0.00114	CcSEcCtD
Terazosin—Dermatitis—Temozolomide—skin cancer	0.000858	0.00114	CcSEcCtD
Terazosin—Headache—Temozolomide—skin cancer	0.000853	0.00114	CcSEcCtD
Terazosin—Hypotension—Docetaxel—skin cancer	0.000846	0.00113	CcSEcCtD
Terazosin—Dizziness—Fluorouracil—skin cancer	0.00083	0.0011	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000825	0.0011	CcSEcCtD
Terazosin—Insomnia—Docetaxel—skin cancer	0.000819	0.00109	CcSEcCtD
Terazosin—Paraesthesia—Docetaxel—skin cancer	0.000813	0.00108	CcSEcCtD
Terazosin—Nausea—Temozolomide—skin cancer	0.000809	0.00108	CcSEcCtD
Terazosin—Dyspnoea—Docetaxel—skin cancer	0.000807	0.00107	CcSEcCtD
Terazosin—Somnolence—Docetaxel—skin cancer	0.000805	0.00107	CcSEcCtD
Terazosin—Vomiting—Fluorouracil—skin cancer	0.000798	0.00106	CcSEcCtD
Terazosin—Dyspepsia—Docetaxel—skin cancer	0.000797	0.00106	CcSEcCtD
Terazosin—Rash—Fluorouracil—skin cancer	0.000791	0.00105	CcSEcCtD
Terazosin—Dermatitis—Fluorouracil—skin cancer	0.00079	0.00105	CcSEcCtD
Terazosin—Decreased appetite—Docetaxel—skin cancer	0.000787	0.00105	CcSEcCtD
Terazosin—Headache—Fluorouracil—skin cancer	0.000786	0.00105	CcSEcCtD
Terazosin—Fatigue—Docetaxel—skin cancer	0.000781	0.00104	CcSEcCtD
Terazosin—Pain—Docetaxel—skin cancer	0.000775	0.00103	CcSEcCtD
Terazosin—Constipation—Docetaxel—skin cancer	0.000775	0.00103	CcSEcCtD
Terazosin—Feeling abnormal—Docetaxel—skin cancer	0.000746	0.000994	CcSEcCtD
Terazosin—Nausea—Fluorouracil—skin cancer	0.000745	0.000992	CcSEcCtD
Terazosin—Gastrointestinal pain—Docetaxel—skin cancer	0.000741	0.000986	CcSEcCtD
Terazosin—Abdominal pain—Docetaxel—skin cancer	0.000716	0.000953	CcSEcCtD
Terazosin—Body temperature increased—Docetaxel—skin cancer	0.000716	0.000953	CcSEcCtD
Terazosin—Hypersensitivity—Docetaxel—skin cancer	0.000667	0.000888	CcSEcCtD
Terazosin—Asthenia—Docetaxel—skin cancer	0.00065	0.000865	CcSEcCtD
Terazosin—Pruritus—Docetaxel—skin cancer	0.000641	0.000853	CcSEcCtD
Terazosin—Diarrhoea—Docetaxel—skin cancer	0.00062	0.000825	CcSEcCtD
Terazosin—Dizziness—Docetaxel—skin cancer	0.000599	0.000797	CcSEcCtD
Terazosin—Vomiting—Docetaxel—skin cancer	0.000576	0.000767	CcSEcCtD
Terazosin—Rash—Docetaxel—skin cancer	0.000571	0.00076	CcSEcCtD
Terazosin—Dermatitis—Docetaxel—skin cancer	0.000571	0.00076	CcSEcCtD
Terazosin—Headache—Docetaxel—skin cancer	0.000567	0.000755	CcSEcCtD
Terazosin—Nausea—Docetaxel—skin cancer	0.000538	0.000716	CcSEcCtD
